CG
RGNX icon

Cutler Group’s Regenxbio RGNX Stock Holding History

Cutler Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,200
Closed -$12K – 4244
2023
Q2 		$12K Sell
1,200
-3,000
-71% -$57.8K ﹤0.01% 2159
2023
Q1 		$31K Buy
4,200
+1,200
+40% +$26.6K ﹤0.01% 1659
2022
Q4 		$13K Sell
3,000
-2,000
-40% -$45.2K ﹤0.01% 2535
2022
Q3 		$6K Hold
5,000
– – ﹤0.01% 3547
2022
Q2 		$20K Buy
+5,000
New +$125K ﹤0.01% 2681
2021
Q4 		– Sell
-6,500
Closed -$7K – 5929
2021
Q3 		$7K Buy
+6,500
New +$234K ﹤0.01% 4239
2020
Q2 		– Sell
-3,200
Closed -$26K – 4778
2020
Q1 		$26K Buy
+3,200
New +$133K ﹤0.01% 2138
2019
Q4 		– Sell
-1,800
Closed -$16K – 4491
2019
Q3 		$16K Sell
1,800
-7,200
-80% -$292K ﹤0.01% 2338
2019
Q2 		$114K Sell
9,000
-4,900
-35% -$245K 0.01% 1026
2019
Q1 		$126K Buy
13,900
+8,700
+167% +$431K 0.01% 882
2018
Q4 		$68K Buy
5,200
+700
+16% +$41.1K 0.01% 1298
2018
Q3 		$20K Buy
+4,500
New +$324K ﹤0.01% 2239
2018
Q2 		– Sell
-2,200
Closed -$5K – 4749
2018
Q1 		$5K Buy
+2,200
New +$64K ﹤0.01% 3302
2017
Q3 		– Sell
-3,500
Closed -$9K – 6556
2017
Q2 		$9K Buy
+3,500
New +$67.8K ﹤0.01% 4281

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Cutler Group's RGNX Position: Q3 2023 in Review

Cutler Group sold out of Regenxbio (RGNX) in Q3 2023, closing a stake of 1,200 shares — an estimated $23K sold.

Cutler Group first reported a position in RGNX in Q3 2017 and held it in 20 quarters. The position peaked at $422K in Q3 2018. 159 funds tracked by Wall St. Rank hold RGNX as of Q3 2023.

  • Cutler Group reported no remaining Regenxbio position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 1,200 Regenxbio shares in Q3 2023, an estimated $23K.
  • Cutler Group first reported a position in Regenxbio in Q3 2017 and held it in 20 quarters.
  • Cutler Group's Regenxbio position peaked at $422K in Q3 2018.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.